Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
RAPA-201 Immunotherapy for Solid Cancers
Recruiting1 awardPhase 1 & 2
Hackensack, New Jersey
This trial tests a new treatment using RAPA-201 cells for patients with advanced solid tumors that have not responded to previous treatments. These reprogrammed immune cells are designed to survive better in tumors and attack cancer cells more effectively. The study aims to see if this new approach can help control tumor growth in these patients.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service